Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials.
Chew, D P
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. [electronic resource] - Internal medicine journal Jul 2002 - 338-45 p. digital
Publication Type: Journal Article; Review
1444-0903
10.1046/j.1445-5994.2002.00226.x doi
Abciximab
Acute Disease
Angina, Unstable--drug therapy
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--pharmacology
Dose-Response Relationship, Drug
Drug Administration Schedule
Eptifibatide
Humans
Immunoglobulin Fab Fragments--pharmacology
Myocardial Infarction--drug therapy
Peptides--pharmacology
Platelet Aggregation Inhibitors--administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Syndrome
Time Factors
Tirofiban
Treatment Outcome
Tyrosine--analogs & derivatives
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. [electronic resource] - Internal medicine journal Jul 2002 - 338-45 p. digital
Publication Type: Journal Article; Review
1444-0903
10.1046/j.1445-5994.2002.00226.x doi
Abciximab
Acute Disease
Angina, Unstable--drug therapy
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--pharmacology
Dose-Response Relationship, Drug
Drug Administration Schedule
Eptifibatide
Humans
Immunoglobulin Fab Fragments--pharmacology
Myocardial Infarction--drug therapy
Peptides--pharmacology
Platelet Aggregation Inhibitors--administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Syndrome
Time Factors
Tirofiban
Treatment Outcome
Tyrosine--analogs & derivatives